Cargando…
FLT3 mutation incidence and timing of origin in a population case series of pediatric leukemia
BACKGROUND: Mutations in FLT3 result in activated tyrosine kinase activity, cell growth stimulation, and a poor prognosis among various subtypes of leukemia. The causes and timing of the mutations are not currently known. We evaluated the prevalence and timing of origin of FLT3 mutations in a popula...
Autores principales: | Chang, Patrick, Kang, Michelle, Xiao, Anny, Chang, Jeffrey, Feusner, James, Buffler, Patricia, Wiemels, Joseph |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955609/ https://www.ncbi.nlm.nih.gov/pubmed/20875128 http://dx.doi.org/10.1186/1471-2407-10-513 |
Ejemplares similares
-
Fetal growth and body size genes and risk of childhood acute lymphoblastic leukemia
por: Chokkalingam, Anand P., et al.
Publicado: (2012) -
The Biology and Targeting of FLT3 in Pediatric Leukemia
por: Annesley, Colleen E., et al.
Publicado: (2014) -
Outcomes of pediatric acute myeloid leukemia patients with FLT3-ITD mutations in the pre-FLT3 inhibitor era
por: Choi, Sujin, et al.
Publicado: (2020) -
“FLipping” the Story: FLT3-Mutated Acute Myeloid Leukemia and the Evolving Role of FLT3 Inhibitors
por: Knight, Tristan E., et al.
Publicado: (2022) -
Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia
por: McCall, David, et al.
Publicado: (2021)